The aim of this study was to evaluate the time to resolution of COVID-19 respiratory and systemic symptoms, and factors associated with a longer duration in a large cohort of outpatients, for whom data is scarce. Results were collected from the over 9000 outpatients, managed by Covidon, a telesurveillance solution.
|